Skip to content

ClearPoint Neuro CLPT Compensation and benefits

Compensation and benefits at other companies

Stryker logo
StrykerSYK
$885M-3.7%
Abbott logo
AbbottABT
IAR
Integra LifeSciencesIART
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Neuropace, Inc. logo
Neuropace, Inc.NPCE
Penumbra logo
PenumbraPEN

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's compensation and benefits?
ClearPoint Neuro (CLPT) reported compensation and benefits of $2.98M in Q1 2026.
How has ClearPoint Neuro's compensation and benefits changed year-over-year?
ClearPoint Neuro's compensation and benefits increased by 53.1% year-over-year, from $1.94M to $2.98M.
What is the long-term trend for ClearPoint Neuro's compensation and benefits?
Over 5 years (2020 to 2025), ClearPoint Neuro's compensation and benefits has grown at a 22.3% compound annual growth rate (CAGR), from $1.6M to $4.36M.